Chamlion Closes 236M Yuan in Series B Funding

Apr 20, 2023 1 min read
Chamlion Closes 236M Yuan in Series B Funding

Originally published by FinSMEs on April 19, 2023

Chamlion, a Nanjing, China-based company focused on the digitalization of processes of dentistry, raised 236M Yuan in Series B funding.

The round was led by 3H Health, followed by Vertex Ventures China, existing shareholder Zhencheng Capital, and Taihe Capital.

The company intends to use the funds to further expand its domestic and overseas business, including the in-depth promotion and upgrade of their existing product line, to consolidate its position in the field of dental digitalization.

Chamlion focuses on realizing the digitalization of the entire process of dentistry with a new generation of technology, and provides one-stop dental 3D printing digital solutions. In May 2021, the company completed rebranding from “Chamlion Laser” to “Chamlion Technology”, and at the same time started an in-depth business model transformation, changing from a traditional 3D printing equipment supplier to a cloud printing service model. The company applies the hardware as a service (HaaS) model in the field of dental 3D printing, intelligently connects 3D printers to the Internet, and builds a large-scale distributed dental manufacturing cloud factory, connecting the data-design-manufacturing process of dental processing, and building a digital service platform for the full process of dentistry.

Based in China and with a global layout, Chamlion has established branches in Vietnam, the United States, France, Turkey, built sales networks and companies covering many countries and regions around the world, and established localized and digital manufacturing centers.

At present, the installed capacity of Chamlion’s metal 3D printers has exceeded 1,000, leading the dental 3D metal printing market.

Prior to this, Chamlion has secured tens of millions of yuan in the A round fundraising invested by Shandong Yinling Industry Investment Co., Ltd. and the 140 million yuan in the A+ round fundraising exclusively invested by Zhencheng Capital. In addition to the B round fundraising, the company’s cumulative fundraising exceeds 400 million yuan.

Great! Next, complete checkout for full access to Agetech News.
Welcome back! You've successfully signed in.
You've successfully subscribed to Agetech News.
Success! Your account is fully activated, you now have access to all content.
Success! Your billing info has been updated.
Your billing was not updated.